Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | -3 | 3,500 | 18,364 | 3,330 | 327 |
| Gross Profit | -3 | 3,500 | 18,364 | 3,330 | 327 |
| Operating Expenses | 4,948 | 3,069 | 4,373 | 2,986 | 4,020 |
| Operating Income | -4,951 | 431 | 13,991 | 344 | -3,693 |
| Other Income | 290 | 129 | 141 | 107 | -114 |
| Pre-tax Income | -4,661 | 560 | 14,132 | 451 | -3,807 |
| Net Income Continuous | -4,661 | 560 | 14,132 | 451 | -3,807 |
| Net Income | $-4,658 | $560 | $14,132 | $451 | $-3,807 |
| EPS Basic Total Ops | -0.11 | 0.01 | 0.30 | 0.01 | -0.07 |
| EPS Basic Continuous Ops | -0.11 | 0.01 | 0.30 | 0.01 | -0.06 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Diluted Total Ops | -0.10 | 0.01 | 0.29 | 0.01 | -0.07 |
| EPS Diluted Continuous Ops | -0.10 | 0.01 | 0.29 | 0.01 | -0.06 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EBITDA(a) | $-4,931 | $454 | $14,015 | $369 | $-3,667 |